Translating Pre-Clinical Research to Clinical Patient Care™


MSACL 2025

Montreal 21-26

Recognition Awards

Recognition Awards

Click Here to Make a Nomination

The Recognition Award program has been established by the Association as a means of recognizing the commitment and achievement of individuals in the field of Clinical Mass Spectrometry. This program is one of the means by which the Association encourages the advancement of mass spectrometry in clinical chemistry via the promotion of research, education and application.

The MSACL Distinguished Contribution Award

In Recognition of Achievements Made in the Field of Clinical Mass Spectrometry that have Furthered the Advancement of Knowledge and the Implementation of Science for the Benefit of Humanity


Representative Award Medal

Self-nominations are not recognized for consideration.

The purpose of the Distinguished Contribution Award is to recognize a contributor who has conducted research, teaching or application of Mass Spectrometry in Clinical Chemistry with significant impact.

Nominations will be evaluated on elements of the following criteria:

  1. Program of research: Quality, scope and overall impact on the profession,
  2. The extent to which the contribution is based on original concepts and/or innovative practices recognized throughout the field over a sustained period,
  3. The impact the contribution has had on the field, including education, influence on practitioners and the care of patients, organizations, thought leaders, and research, and
  4. Influence on research advancement and career development within the profession

Nomination Application Information should include:

  1. The basic contact info of the nominee.
  2. A concise summary of the applicant's accomplishments and/or contributions.
  3. The basic contact info of the nominator.

The Award recognizes a focused or singular achievement in education, technology development or applied mass spectrometry in clinical chemistry. The award will be conferred at the annual MSACL conference.


2015 US: David Millington
Tandem Mass Spectrometry in Clinical Diagnostics, Newborn Screening and Targeted Metabolomics

2015 EU: Linda Thienpont
Mass Spectrometry as Metrological Anchor in Laboratory Medicine – a Meandering River

2016 US: Kenneth Setchell
What We Can Learn from a Drop of Urine – Metabolomics at It's Earliest: Discoveries of Bile Acid Synthesis Disorders, a New Category of Fatal Metabolic Liver Disease and Development of a Treatment

2017 US: Catherine Feneslau
Rapid Characterization of Microorganisms by Mass Spectrometry: What can be Learned and How?

2017 EU: Isabelle Fournier
Laser-based Mass Spectrometry in Clinics: Changing the Paradigm of Molecular Diagnosis

2018 US: Richard Yost
The Triple Quadrupole: Innovation, Serendipity and Persistence

2018 EU: Cedric Shackleton
Mass Spectrometry and the Elucidation of Steroid Metabolome

2019 US: Donald Hunt
Immunotherapy of Cancer and the Role of Mass Spectrometry; An Overview and New Results

2019 EU: Zoltan Takats
15 years of Ambient Mass Spectrometry: From Amino Acid Clusters to Surgical Robotics

2020 US: Alan Rockwood
My Path to Enlightenment, or How I Became a Clinical Mass Spectrometrist and Clinical Chemist

2023: Jennifer Van Eyk
The Next Phase of Precision Medicine

2024: Russell Grant
Grit and Guinness; Confronting Bias and Imprecision without Compromising Scalability


The MSACL 2025 application deadline is January 7, 2025.

Selection Procedure:

Award winner to receive notification by March 15, 2025 and to be be honored during the MSACL 2025 Montreal Conference.